BUSM Awarded $4.1M to Support the Next Generation of Trail-blazers in Multidisciplinary Lung Science
We are so pleased that “Biology of the Lung: A Multi-Disciplinary Program” has been renewed! The current cycle is funded for five years, from July 1, 2021 until June 30, 2026. This T32 grant provides multidisciplinary training in collaborative lung biology and pulmonary medicine research, in three scientific areas that are special strengths of the […]
Antibodies Produced in the Lung Can Prevent Respiratory Infections from Becoming Severe
Researchers in the Pulmonary Center, led by Dr. Jay Mizgerd, have discovered that after recovering from a respiratory infection, new B cells get deposited in lung tissue, persist there, and then become antibody secreting cells very quickly if the lungs get infected again later by something similar. They showed that antibodies made by B cells […]
Recent Awards for Trainees
Congratulations to these Pulmonary Center trainees who were recently successful in receiving extramural training awards: Claire Burgess Ph.D. Student, Mentor: Darrell Kotton NIH F31 Predoctoral Fellowship Award “Generation of human alveolar epithelial type I cells from pluripotent stem cells” Senegal Carty Ph.D. Student, Mentor: Matt Jones American Heart Association Predoctoral Fellowship Award “Pulmonary Lymphatic Endothelial […]
2021 ATS Awards
Justin Lui, M.D. Pulmonary Fellow, Mentor: Klings/Wiener 2021 ATS Ziskind Clinical Research Scholar Award “The Ziskind Clinical Research Scholar Award is an ATS Scholarship Award that honors pulmonary and critical care fellows engaged in clinical research. The award was named after Morton Ziskind, MD, a highly respected clinician-researcher from Tulane University who died in 1979 […]
PhD Candidate Kiloni Quiles-Franco Featured in Podcast Interview
Kiloni Quiles-Franco is a PhD candidate in the labs of Felicia Chen MD in the Pulmonary Center and Evan Johnson PhD in the Division of Computational Biomedicine at Boston University School of Medicine. Kiloni is engaged in a number of on- and off-campus initiatives focused on equity and inclusion, such as the Women’s Professional Development […]
New ways to attack necrotic tuberculous granulomas in the lung
Approximately one quarter of all humans have been infected during their lifetime with Mycobacterium tuberculosis – the bacteria that causes tuberculosis (TB). Most of the infected people control the bacteria that remain dormant for many years. In some individuals, however, the bacteria grow in the lungs, causing severe lung damage, including the formation of necrosis […]
Dr. O’Connor and the New Asthma Guidelines
George O’Connor, MD, MS, a Pulmonary Center faculty member and associate editor of JAMA, and Stephanie Lovinsky-Desir, MD, MS from Columbia University, wrote an editorial (1) in the December 8, 2020 issue of JAMA on a new update to the NIH asthma guidelines (2) that was also published in that issue of JAMA. Drs. O’Connor […]
Actionable Lung Cell Responses to SARS-CoV-2 Infection
Teams from Pulmonary Center Faculty members Andrew Wilson and Darrell Kotton (and collaborators) recently published exciting new findings about how alveolar epithelial type 2 cells respond to SARS-CoV-2 infection! “Briefly, we found that there are changes to cellular proteins (the proteome and phosphoproteome) that occur as soon as 1 hour […]
COVID-19 study spanning 275 hospitals and 23 countries
Dr. Walkey is co-Principal Investigator for the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study. This study, funded in part by the Gordon and Betty Moore Foundation, created an international registry that supplies de-identified clinical data from more than 40,000 patients at 275 hospitals in 23 countries for the conduct […]
Past infections with other coronaviruses influence COVID-19
Endemic coronaviruses have been causing human infections for many years, long before the recent emergence of SARS-CoV-2 which causes COVID-19. Jay Mizgerd and Manish Sagar (from the Section of Infectious Diseases) hypothesized that infections with endemic coronavirus, which are molecularly similar to SARS-CoV-2, might elicit cross-reactive immunity that influences what happens during a SARS-CoV-2 infection. […]